Viewing StudyNCT00000825



Ignite Creation Date: 2024-05-05 @ 11:22 AM
Last Modification Date: 2024-10-26 @ 9:02 AM
Study NCT ID: NCT00000825
Status: COMPLETED
Last Update Posted: 2021-10-29
First Post: 1999-11-02

Brief Title: The Effects of Giving Interleukin-2 IL-2 Plus Anti-HIV Therapy to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cellsmm3
Sponsor: National Institute of Allergy and Infectious Diseases NIAID
Organization: National Institute of Allergy and Infectious Diseases NIAID

Conditions & Keywords Data

Conditions:
Name
HIV Infections
Keywords:
Name View
HIV-1 View
Interleukin-2 View
Dose-Response Relationship Drug View
Antiviral Agents View
CD4 Lymphocyte Count View
DNA Viral View